FdaApplication

ANDA 205504

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHETERO LABS LTD UNIT V
application_typeANDA
approval_date2024-01-04

Products (3)

ProductActive ingredientStrengthDosage form
ESZOPICLONEESZOPICLONE2MGTABLET;ORAL
ESZOPICLONEESZOPICLONE1MGTABLET;ORAL
ESZOPICLONEESZOPICLONE3MGTABLET;ORAL

3 products